566 related articles for article (PubMed ID: 26610594)
1. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
[TBL] [Abstract][Full Text] [Related]
2. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
3. Differences in Initial Hemodialysis Vascular Access Use Among Glomerulonephritis Subtypes in the United States.
O'Shaughnessy MM; Montez-Rath ME; Zheng Y; Lafayette RA; Winkelmayer WC
Am J Kidney Dis; 2016 Apr; 67(4):638-47. PubMed ID: 26774466
[TBL] [Abstract][Full Text] [Related]
4. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
OʼShaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Transplantation; 2017 Oct; 101(10):2636-2647. PubMed ID: 28207635
[TBL] [Abstract][Full Text] [Related]
5. Kidney Transplantation Outcomes across GN Subtypes in the United States.
O'Shaughnessy MM; Liu S; Montez-Rath ME; Lenihan CR; Lafayette RA; Winkelmayer WC
J Am Soc Nephrol; 2017 Feb; 28(2):632-644. PubMed ID: 27432742
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Glomerulonephritis in Renal Transplantation: Experience in Our Renal Transplantation Center.
Cañas L; López D; Pérez JF; Bancu I; Juega J; Ariza A; Bonet J; Lauzurica R
Transplant Proc; 2015 Oct; 47(8):2354-6. PubMed ID: 26518925
[TBL] [Abstract][Full Text] [Related]
7. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
8. Incidence of glomerulonephritis and non-diabetic end-stage renal disease in a developing middle-east region near armed conflict.
Ali AA; Sharif DA; Almukhtar SE; Abd KH; Saleem ZSM; Hughson MD
BMC Nephrol; 2018 Oct; 19(1):257. PubMed ID: 30305040
[TBL] [Abstract][Full Text] [Related]
9. Changing prevalence of glomerular diseases in Korean adults: a review of 20 years of experience.
Chang JH; Kim DK; Kim HW; Park SY; Yoo TH; Kim BS; Kang SW; Choi KH; Han DS; Jeong HJ; Lee HY
Nephrol Dial Transplant; 2009 Aug; 24(8):2406-10. PubMed ID: 19264742
[TBL] [Abstract][Full Text] [Related]
10. End-Stage Renal Disease and Mortality Outcomes Across Different Glomerulonephropathies in a Large Diverse US Population.
Sim JJ; Bhandari SK; Batech M; Hever A; Harrison TN; Shu YH; Kujubu DA; Jonelis TY; Kanter MH; Jacobsen SJ
Mayo Clin Proc; 2018 Feb; 93(2):167-178. PubMed ID: 29395351
[TBL] [Abstract][Full Text] [Related]
11. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
12. ESRD outcomes and GN subtypes.
Young EW
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1117-8. PubMed ID: 26092826
[No Abstract] [Full Text] [Related]
13. Effect of organic solvent exposure on chronic kidney disease progression: the GN-PROGRESS cohort study.
Jacob S; Héry M; Protois JC; Rossert J; Stengel B
J Am Soc Nephrol; 2007 Jan; 18(1):274-81. PubMed ID: 17135394
[TBL] [Abstract][Full Text] [Related]
14. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
Pham PT; Pham PC
Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of clinical outcomes comparison between different initial dialysis modalities in end-stage renal disease patients due to lupus nephritis prior to renal transplantation.
Swai J; Zhao X; Noube JR; Ming G
BMC Nephrol; 2020 May; 21(1):156. PubMed ID: 32357924
[TBL] [Abstract][Full Text] [Related]
16. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
O'Shaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Eur Heart J; 2019 Mar; 40(11):887-898. PubMed ID: 30085056
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathologic predictors of recurrent glomerulonephritis after kidney transplantation.
Chukwu CA; Holmberg C; Storrar J; Middleton R; Sinha S; Kalra PA; Shawki H; Rao A
Clin Transplant; 2023 Jun; 37(6):e14970. PubMed ID: 36950848
[TBL] [Abstract][Full Text] [Related]
18. Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA?
Nair R; Walker PD
Kidney Int; 2006 Apr; 69(8):1455-8. PubMed ID: 16531983
[TBL] [Abstract][Full Text] [Related]
19. Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
Lionaki S; Makropoulos I; Panagiotellis K; Vlachopanos G; Gavalas I; Marinaki S; Liapis G; Michelakis I; Bokos I; Boletis I
PLoS One; 2021; 16(8):e0253337. PubMed ID: 34403416
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence and improved prognosis of glomerulonephritis: a national 30-year study.
Heaf JG; Sørensen SS; Hansen A
Clin Kidney J; 2021 Jun; 14(6):1594-1602. PubMed ID: 34084455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
